1532 studies found for:    "Alzheimer disease familial"
Show Display Options
Download search resultsDownload the search results for:
"Alzheimer disease familial" (1532 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Alzheimer's Disease Genetics Study
Conditions: Alzheimer Disease;   Late Onset Alzheimer Disease;   Dementia
Intervention:
2 Active, not recruiting Randomized Trial of Low-dose Naproxen in Cognitively Intact Persons at Risk of Alzheimer's Dementia
Conditions: Alzheimer Disease;   Cognitive Decline Due to Alzheimer Disease;   Mild Cognitive Impairment Due to Alzheimer Disease
Interventions: Drug: Naproxen;   Drug: Placebo
3 Active, not recruiting Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
Conditions: Alzheimers Disease;   Dementia;   Alzheimers Disease, Familial
Interventions: Drug: Gantenerumab;   Drug: Solanezumab;   Drug: Matching Placebo (Gantenerumab);   Drug: Matching Placebo (Solanezumab)
4 Recruiting Sleep Apnea in Early to Mid-Stage Alzheimer's Disease
Conditions: Early Onset Alzheimer Disease;   Alzheimer Disease;   Obstructive Sleep Apnea Syndromes
Interventions: Device: CPAP Treatment;   Device: No treatment
5 Completed Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's Disease
Conditions: Alzheimer's Disease;   Mild to Moderate Alzheimers Disease
Interventions: Drug: GSK239512;   Drug: Placebo
6 Completed A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease
Conditions: Mild-to-moderate Alzheimer's Disease;   Alzheimer's Disease
Interventions: Drug: SB-742457 15mg;   Drug: SB-742457 35mg;   Drug: Placebo;   Drug: donepezil 5-10mg
7 Completed Alzheimer's Disease Prevention Trial
Conditions: Alzheimer Disease;   Memory Disorders
Interventions: Drug: Estrogen;   Drug: Estrogen and Progesterone
8 Completed Development of NIC5-15 in the Treatment of Alzheimer's Disease
Conditions: Alzheimer Disease;   Dementia
Interventions: Drug: NIC5-15;   Drug: Placebo
9 Unknown  A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia
Interventions: Drug: Drug: NIC5-15;   Drug: Placebo
10 Unknown  Far Infrared Treatment for Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
11 Completed Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention:
12 Recruiting Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019)
Conditions: Amnestic Mild Cognitive Impairment;   Alzheimer's Disease;   Prodromal Alzheimer's Disease
Interventions: Drug: Verubecestat (Part I and Part II);   Drug: Placebo (Part I);   Drug: Verubecestat (Part II)
13 Completed Sunphenon EGCg (Epigallocatechin-Gallate) in the Early Stage of Alzheimer´s Disease
Condition: Alzheimer's Disease
Interventions: Drug: Epigallocatechin-Gallate;   Drug: Placebo
14 Completed
Has Results
Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Memantine;   Drug: Placebo
15 Completed Alzheimer's Disease: Therapeutic Potential of Estrogen
Condition: Alzheimer Disease
Interventions: Drug: Transdermal estradiol;   Drug: Medroxyprogesterone;   Drug: Placebo Patch;   Drug: Placebo
16 Completed Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: TRx0237 200 mg/day;   Drug: Placebo
17 Completed Memantine for Agitation and Aggression in Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: memantine
18 Active, not recruiting Alzheimer's Disease Neuroimaging Initiative 2
Conditions: Mild Cognitive Impairment (MCI);   Alzheimer's Disease (AD);   Significant Memory Concern (SMC);   Early Mild Cognitive Impairment (EMCI);   Late Mild Cognitive Impairment (LMCI)
Intervention:
19 Completed Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: TRx0237 150 mg/day;   Drug: TRx0237 250 mg/day;   Drug: Placebo
20 Unknown  Disease-modifying Properties of Lithium in the Neurobiology of Alzheimer's Disease
Conditions: Cognitive Impairment;   Alzheimer Disease
Interventions: Drug: Lithium Carbonate;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years